CURATIVE BIOTECHNOLOGY, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0128 USD | -27.14% |
|
-42.05% | -40.14% |
| 05-06 | Curative Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million. | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2023 |
|---|---|---|---|---|
| Capitalization 1 | 0.7263 | 9.749 | 29.41 | 13.47 |
| Enterprise Value (EV) 1 | 0.8511 | 10.15 | 28.74 | 15.67 |
| P/E ratio | 6.05 x | -2.11 x | -1.44 x | -3.56 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | - | - | - | - |
| EV / Revenue | - | - | - | - |
| EV / EBITDA | -5,674 x | -2.21 x | -5.75 x | -8.54 x |
| EV / FCF | - | - | 13,343,280 x | -6,247,849 x |
| FCF Yield | - | - | 0% | -0% |
| Price to Book | -8.21 x | -2.22 x | -1.88 x | -4.49 x |
| Nbr of stocks (in thousands) | 322,800 | 322,800 | 544,542 | 632,494 |
| Reference price 2 | 0.002250 | 0.0302 | 0.0540 | 0.0213 |
| Announcement Date | 24/11/21 | 24/11/21 | 15/04/22 | 06/05/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2023 |
|---|---|---|---|---|
| Net sales | - | - | - | - |
| EBITDA 1 | -0.00015 | -4.598 | -4.997 | -1.835 |
| EBIT 1 | -0.005451 | -4.604 | -4.997 | -1.933 |
| Operating Margin | - | - | - | - |
| Earnings before Tax (EBT) 1 | 0.2072 | -4.67 | -5.34 | -3.957 |
| Net income 1 | 0.2072 | -4.67 | -5.34 | -3.957 |
| Net margin | - | - | - | - |
| EPS 2 | 0.000372 | -0.0143 | -0.0376 | -0.005975 |
| Free Cash Flow | - | - | 2.154 | -2.509 |
| FCF margin | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 24/11/21 | 24/11/21 | 15/04/22 | 06/05/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2023 |
|---|---|---|---|---|
| Net Debt 1 | 0.12 | 0.4 | - | 2.2 |
| Net Cash position 1 | - | - | 0.67 | - |
| Leverage (Debt/EBITDA) | -832 x | -0.0868 x | - | -1.2 x |
| Free Cash Flow | - | - | 2.15 | -2.51 |
| ROE (net income / shareholders' equity) | - | -613% | -325% | 139% |
| ROA (Net income/ Total Assets) | - | -249% | -133% | -51.8% |
| Assets 1 | - | 1.878 | 4.006 | 7.641 |
| Book Value Per Share 2 | -0 | -0.0100 | -0.0300 | -0 |
| Cash Flow per Share | - | 0 | 0 | 0 |
| Capex | - | - | 0.01 | - |
| Capex / Sales | - | - | - | - |
| Announcement Date | 24/11/21 | 24/11/21 | 15/04/22 | 06/05/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -40.14% | 15.81M | |
| +33.63% | 50.85B | |
| -0.09% | 42.82B | |
| +49.62% | 42.03B | |
| -4.96% | 29.55B | |
| +11.18% | 26.11B | |
| -21.95% | 19.13B | |
| +8.61% | 13.05B | |
| +28.31% | 12.16B | |
| +24.73% | 12.08B |
- Stock Market
- Equities
- CUBT Stock
- Financials Curative Biotechnology, Inc.
